Response to concerns over Cantillon et al. dopamine serotonin stabilizer RP5063 clinical trial's design, analyses and findings (SCHRES-D-17-00455) by Ahmed S Aboraya, MD, DrPh
| Autor: | Cantillon, Marc, Bhat, Laxminarayan |
|---|---|
| Zdroj: | In Schizophrenia Research May 2018 195:581-582 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect